⌕
Immunocore Holdings · IMCR · Nasdaq
Tenet 53 · Mixed
Compare
$27.81−3.71%At closeTenet 53 · Mixed
$27.81−1.07 (−3.71%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Immunocore Holdings (IMCR) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

1 figure withheld by our checks. Each blank figure names its reason.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (6 new · 26 increased · 14 reduced · 8 closed · 1 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 55 filers, Sep 30, 2026
# 13F FUNDS
55
13F VALUE
$312.3M
10.3M shares
Withheld: 13F filers report depositary receipts and the company reports ordinary shares, so the two do not divide.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
May 27, 2026Bell John IrvingdirectorAcquired · Grant / award27,492Share Option (Right to Buy)—↗
May 27, 2026Kaul SiddharthdirectorAcquired · Grant / award27,492Share Option (Right to Buy)—↗
May 27, 2026Herbst Roy StevendirectorAcquired · Grant / award27,492Share Option (Right to Buy)—↗
May 27, 2026Ratcliffe Peter JohndirectorAcquired · Grant / award27,492Share Option (Right to Buy)—↗
May 27, 2026Pao WilliamdirectorAcquired · Grant / award27,492Share Option (Right to Buy)—↗
May 27, 2026Peterson KristinedirectorAcquired · Grant / award27,492Share Option (Right to Buy)—↗
Feb 18, 2026St Leger Tina AmberCHIEF HR OFFICERDisposed · Open-market sale1,000$32.35↗
Feb 18, 2026Berman David MHEAD OF R&DDisposed · Open-market sale5,965$32.35↗
Feb 18, 2026GOLL JOHNSVP, FINANCE & CAODisposed · Open-market sale698$32.35↗
Feb 18, 2026Jallal BahijaCHIEF EXECUTIVE OFFICERDisposed · Open-market sale11,474$32.35↗
Feb 17, 2026St Leger Tina AmberCHIEF HR OFFICERAcquired · Option exercise2,119—↗
Feb 17, 2026St Leger Tina AmberCHIEF HR OFFICERDisposed · Option exercise2,119Restricted Share Units—↗
Feb 17, 2026Coy Travis AlanChief Financial OfficerAcquired · Grant / award33,353Restricted Share Units—↗
Feb 17, 2026Coy Travis AlanChief Financial OfficerAcquired · Grant / award95,637Employee Share Option (Right to Buy)—↗
Feb 17, 2026Berman David MHEAD OF R&DAcquired · Option exercise11,824—↗
Feb 17, 2026Berman David MHEAD OF R&DDisposed · Option exercise11,824Restricted Share Units—↗
Feb 17, 2026GOLL JOHNSVP, FINANCE & CAOAcquired · Option exercise1,351—↗
Feb 17, 2026GOLL JOHNSVP, FINANCE & CAODisposed · Option exercise1,351Restricted Share Units—↗
Feb 17, 2026GOLL JOHNSVP, FINANCE & CAOAcquired · Grant / award7,411Restricted Share Units—↗
Feb 17, 2026GOLL JOHNSVP, FINANCE & CAOAcquired · Grant / award21,252Employee Share Option (Right to Buy)—↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How many 13F filers hold Immunocore Holdings?

Immunocore Holdings was held by 55 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.